L1 Recombinant Proteins of HPV Tested for Antibody Forming Using Sera of HPV Quadrivalent Vaccine

Virus-like particles (VLPs) derived from human papillomavirus (HPV) L1 capsid proteins were used for HPV quadrivalent recombinant vaccine. The HPV quadrivalent vaccine is administrated in a 3-dose regimen of initial injection followed by subsequent doses at 2 and 6 months to prevent cervical cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Akuzum, Begum, Kim, Sinae, Nguyen, Tam Thanh, Hong, Jeawoo, Lee, Siyoung, Kim, Eunhye, Kim, Joohee, Choi, Yeook, Jhun, Hyunjhung, Lee, Youngmin, Kim, Hyunwoo, Sohn, Dong Hyun, Kim, Soohyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Immunologists 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026689/
https://www.ncbi.nlm.nih.gov/pubmed/29984037
http://dx.doi.org/10.4110/in.2018.18.e19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026689/
https://www.ncbi.nlm.nih.gov/pubmed/29984037
http://dx.doi.org/10.4110/in.2018.18.e19

Ejemplares similares